Motion Medical research facilities will be located in the Discovery Square research district’s bioscience centre called One Discovery Square. Credit: Mayo Clinic.

Medical devices manufacturer Boston Scientific has partnered with Mayo Clinic, a non-profit academic medical centre, to launch an accelerator focused on medical solutions for diseases with unmet clinical needs.

Named Motion Medical, the new 1,800ft² venture will receive funds from partners over three years to develop new medical technology and minimally invasive therapies.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Motion Medical research facilities will be located in the Discovery Square research district’s bioscience centre called One Discovery Square in Rochester, Minnesota, US.

Boston Scientific and Mayo Clinic have been working together for approximately ten years for the development of medical devices and technologies across interventional cardiology, neuromodulation and urology therapeutic areas, among others.

To date, the companies have submitted eight patent applications and partnered on two first-in-human clinical trials, according to Mayo Clinic.

The new venture is expected to further integrate Boston Scientific’s expertise in engineering, innovation and business with Mayo Clinic’s clinical experience and patient care.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Boston Scientific chairman and CEO Mike Mahoney said: “This collaboration between Mayo Clinic and Boston Scientific builds on our experience working together to support the shared goal of advancing patient-centred innovation.

“This approach combines the unique strengths of our two organisations, and we look forward to working together to solve complex healthcare challenges.”

Boston Scientific develops a variety of medical solutions for endoscopy, rhythm management, interventional cardiology, peripheral interventions, neuromodulation, urology and pelvic health.

In November last year, the company signed an agreement to buy BTG for £3.3bn. BTG has three main businesses and Interventional Medicine is said to be the largest.

The acquisition is expected to help boost Boston Scientific’s capabilities in cancer and pulmonary embolism.

Medical Device Network Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Medical Device Network Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving medical devices advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now